CVD : Analysis & Opinions

  1. Healthways Prices Senior Notes - Analyst Blog

    July 3, 2013
    Healthways prices cash convertible senior notes worth $125 million.
  2. Mixed 4Q for Charles River - Analyst Blog

    February 14, 2013
    Charles River Laboratories (CRL) reported fourth quarter 2012 earnings (excluding special items) of 64 cents per share, beating ...
  3. All-Front Easy Beat for Covance - Analyst Blog

    January 28, 2013
    Covance Inc. (CVD) reported earnings per share (EPS) of 61 cents in the fourth quarter of 2012, higher than the year-ago ...
  4. Novo Nordisk A/S and More Big Movers in Healthcare on November ...

    November 6, 2012
    The Nasdaq remains relatively unchanged, the S&P 500 has climbed 0.4% and the Dow is trading up 0.6% so far today. The healthcare ...
  5. PPD Goes Private

    October 6, 2011
    PPD's acceptance of a low buyout bid raises questions about the CRO industry.
  6. Icon Still Optimistic About Helping Big Pharma

    March 2, 2011
    Icon still has a stellar growth track record and industry trends suggest there could be much growth for the company.
  7. Playing Big Pharma With CROs

    July 6, 2010
    Investors looking to play the growth in R&D spending for human drugs should consider CROs.
  8. Secondary Play On Healthcare

    August 15, 2008
    Contract research organizations are an unexplored niche of the healthcare sector. As a whole, they've reported blockbuster ...
  9. Contract Biotech Is Booming (MDZ, CRL, CVD)

    October 1, 2007
    We examine three companies that the big drug makers call on when they need a little testing done.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center